Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for MS
Study Title
- A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis
Teva Identifier
- PM025
ClinicalTrials.gov Identifier
- NCT00203086
Study Status
- Completed
Trial Condition(s)
- Relapsing Remitting Multiple Sclerosis
Interventions
- Drug: Copaxoneֲ®
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 20 Years to 57 Years
Trial Duration
- 10/01/2005 - 12/01/2009
Study Type
Observational